Related Experiment Video

Updated: Apr 25, 2026

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers
12:22

The Use of Reverse Phase Protein Arrays RPPA to Explore Protein Expression Variation within Individual Renal Cell Cancers

Published on: January 22, 2013

33.1K

Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas

Shuigen Zhou1, Longxin Wang1, Guimei Li2

  • 1Department of Urology, Jinling Hospital, Nanjing University School of Medicine Nanjing 210002, P.R. China.

International Journal of Clinical and Experimental Pathology
|August 15, 2014
PubMed

Insights

EphB1 receptor tyrosine kinase expression is decreased in renal cell carcinoma (RCC) tissues compared to normal kidney. This reduced EphB1 protein may play a role in kidney cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The EphB1 receptor tyrosine kinase is implicated in various human cancers, often showing down-regulation.
  • Decreased EphB1 expression correlates with cancer invasion and metastasis.
  • The specific role of EphB1 in renal cell carcinoma (RCC) remains largely unexplored.

Purpose of the Study:

  • To investigate the expression levels and potential role of EphB1 in renal cell carcinoma (RCC).

Main Methods:

  • Immunohistochemistry was employed to assess EphB1 protein expression in 82 surgically resected RCC specimens.
  • Expression levels were compared between different RCC subtypes (clear-cell, papillary, chromophobic) and normal renal tubule epithelium.

Main Results:

  • EphB1 protein is normally expressed in the epithelium of renal tubules.
  • All RCC subtypes exhibited decreased EphB1 expression compared to normal tissue.
  • Expression varied by subtype: moderate in chromophobic, weak in clear-cell, and negative in papillary RCC.

Conclusions:

  • EphB1 down-regulation is a feature of renal cell carcinoma (RCC).
  • EphB1 may be involved in the carcinogenesis of RCC.
  • Further research is needed to elucidate the molecular mechanisms and specific roles of EphB1 in RCC occurrence and progression.
Keywords:
EphB1down-regulationrenal cell carcinoma

More Related Videos

Dissection and Culture of Mouse Embryonic Kidney08:30

Dissection and Culture of Mouse Embryonic Kidney

Published on: May 17, 2017

11.4K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

13.1K

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.5K